Metropolitan Life Insurance Company (MetLife)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-102,204
Closed -$13.5M 1314
2024
Q1
$13.5M Sell
102,204
-942
-0.9% -$116K 0.59% 25
2023
Q4
$11.2M Sell
103,146
-1,842
-2% -$191K 0.53% 26
2023
Q3
$10.8M Sell
104,988
-5,592
-5% -$603K 0.56% 28
2023
Q2
$12.8M Sell
110,580
-2,823
-2% -$321K 0.62% 25
2023
Q1
$12.1M Sell
113,403
-27,289
-19% -$2.95M 0.62% 26
2022
Q4
$15.6M Sell
140,692
-10,129
-7% -$1.04M 0.7% 27
2022
Q3
$13M Sell
150,821
-1,494
-1% -$133K 0.62% 27
2022
Q2
$13.9M Sell
152,315
-3,563
-2% -$316K 0.61% 27
2022
Q1
$12.8M Sell
155,878
-133,047
-46% -$10.5M 0.46% 40
2021
Q4
$22.1M Sell
288,925
-6,239
-2% -$497K 0.3% 56
2021
Q3
$22.2M Sell
295,164
-10,185
-3% -$775K 0.32% 55
2021
Q2
$23.7M Sell
305,349
-140,609
-32% -$10.5M 0.33% 48
2021
Q1
$32.8M Sell
445,958
-25,441
-5% -$1.88M 0.49% 24
2020
Q4
$36.8M Sell
471,399
-18,987
-4% -$1.45M 0.55% 24
2020
Q3
$38.8M Sell
490,386
-19,327
-4% -$1.51M 0.66% 21
2020
Q2
$37.6M Sell
509,713
-6,166
-1% -$464K 0.67% 20
2020
Q1
$37.9M Sell
515,879
-7,141
-1% -$561K 0.78% 15
2019
Q4
$45.4M Sell
523,020
-3,259
-0.6% -$268K 0.72% 15
2019
Q3
$42.3M Buy
526,279
+116,527
+28% +$9.34M 0.72% 17
2019
Q2
$32.8M Buy
409,752
+30,664
+8% +$2.35M 0.55% 29
2019
Q1
$30.1M Sell
379,088
-19,028
-5% -$1.42M 0.55% 30
2018
Q4
$29M Sell
398,116
-15,461
-4% -$1.09M 0.58% 29
2018
Q3
$28M Sell
413,577
-20,053
-5% -$1.28M 0.47% 34
2018
Q2
$25.1M Sell
433,630
-12,377
-3% -$698K 0.41% 42
2018
Q1
$23.2M Sell
446,007
-2,466
-0.5% -$133K 0.33% 46
2017
Q4
$24.1M Sell
448,473
-914,471
-67% -$50.7M 0.32% 47
2017
Q3
$83.3M Sell
1,362,944
-24,416
-2% -$1.48M 0.52% 32
2017
Q2
$84.8M Sell
1,387,360
-36,464
-3% -$2.22M 0.59% 32
2017
Q1
$86.3M Sell
1,423,824
-27,267
-2% -$1.65M 0.6% 29
2016
Q4
$81.5M Sell
1,451,091
-49,708
-3% -$2.91M 0.59% 30
2016
Q3
$89.4M Sell
1,500,799
-11,996
-0.8% -$701K 0.65% 23
2016
Q2
$83.2M Sell
1,512,795
-36,095
-2% -$1.92M 0.62% 25
2016
Q1
$78.2M Sell
1,548,890
-42,093
-3% -$2.06M 0.6% 29
2015
Q4
$80.2M Sell
1,590,983
-24,165
-1% -$1.22M 0.62% 29
2015
Q3
$76.1M Sell
1,615,148
-34,107
-2% -$1.81M 0.55% 32
2015
Q2
$89.6M Sell
1,649,255
-17,522
-1% -$983K 0.63% 25
2015
Q1
$91.4M Sell
1,666,777
-28,834
-2% -$1.63M 0.67% 20
2014
Q4
$91.9M Sell
1,695,611
-34,845
-2% -$1.94M 0.64% 23
2014
Q3
$97.9M Sell
1,730,456
-47,217
-3% -$2.65M 0.7% 21
2014
Q2
$98.1M Sell
1,777,673
-83,145
-4% -$4.54M 0.68% 19
2014
Q1
$101M Sell
1,860,818
-18,018
-1% -$933K 0.7% 19
2013
Q4
$89.7M Sell
1,878,836
-16,649
-0.9% -$761K 0.63% 23
2013
Q3
$86.1M Sell
1,895,485
-68,009
-3% -$3.11M 0.66% 22
2013
Q2
$87M Buy
+1,963,494
New +$87.7M 0.69% 21

Other funds holding MRK

Metropolitan Life Insurance Company (MetLife)'s MRK Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Merck (MRK) in Q2 2024, closing a stake of 102,204 shares — an estimated $13.5M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in MRK in Q2 2013 and held it in 44 quarters. The position peaked at $101M in Q1 2014. 3,547 funds tracked by Wall St. Rank hold MRK as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Merck position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 102,204 Merck shares in Q2 2024, an estimated $13.5M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Merck in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Merck position peaked at $101M in Q1 2014.
  • 3,547 funds tracked by Wall St. Rank held Merck as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.